| Product Information |
|
| Registration Number |
BR-1455
|
| Generic Name |
Respiratory Syncytial Virus Vaccine (Recombinant, Adjuvanted)
|
| Brand Name |
Arexvy
|
| Dosage Strength |
120 mcg
|
| Dosage Form |
Powder for Suspension for Injection (IM)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
See packaging on the reverse side.
|
| Pharmacologic Category |
-
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
GlaxoSmithKline Philippines, Inc.
|
| Application Type |
Monitored Release (MR)
|
| Issuance Date |
22 November 2023
|
| Expiry Date |
22 November 2028
|